vs
帕兰提尔科技（PLTR）与Ventas（VTR）财务数据对比。点击上方公司名可切换其他公司
Ventas的季度营收约是帕兰提尔科技的1.2倍（$1.7B vs $1.4B），帕兰提尔科技净利率更高（43.3% vs 3.6%，领先39.7%），帕兰提尔科技同比增速更快（70.0% vs 22.0%），过去两年帕兰提尔科技的营收复合增速更高（48.9% vs 17.5%）
帕兰提尔科技是美国上市企业，专注研发数据集成与分析平台，为政府机构、军方及各行业企业提供多源数据整合分析能力。旗下核心产品Gotham与Foundry可打通相互孤立的数据库，广泛支撑情报作业、反恐分析、执法工作及企业级数据分析场景。
Ventas是一家领先的医疗地产投资信托企业，旗下资产涵盖养老社区、医疗办公楼、生命科学研究设施及康复医疗中心等，主要在北美、英国地区运营，为医疗服务及生命科学机构提供专业物业解决方案。
PLTR vs VTR — 直观对比
营收规模更大
VTR
是对方的1.2倍
$1.4B
营收增速更快
PLTR
高出48.0%
22.0%
净利率更高
PLTR
高出39.7%
3.6%
两年增速更快
PLTR
近两年复合增速
17.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.7B |
| 净利润 | $608.7M | $59.0M |
| 毛利率 | 84.6% | — |
| 营业利润率 | 40.9% | — |
| 净利率 | 43.3% | 3.6% |
| 营收同比 | 70.0% | 22.0% |
| 净利润同比 | 670.4% | 19.0% |
| 每股收益（稀释后） | $0.24 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLTRVTR
| Q1 26 | — | $1.7B | ||
| Q4 25 | $1.4B | $1.6B | ||
| Q3 25 | $1.2B | $1.5B | ||
| Q2 25 | $1.0B | $1.4B | ||
| Q1 25 | $883.9M | $1.4B | ||
| Q4 24 | $827.5M | $1.3B | ||
| Q3 24 | $725.5M | $1.2B | ||
| Q2 24 | $678.1M | $1.2B |
净利润PLTRVTR
| Q1 26 | — | $59.0M | ||
| Q4 25 | $608.7M | $73.0M | ||
| Q3 25 | $475.6M | $68.7M | ||
| Q2 25 | $326.7M | $71.5M | ||
| Q1 25 | $214.0M | $48.4M | ||
| Q4 24 | $79.0M | $58.7M | ||
| Q3 24 | $143.5M | $21.0M | ||
| Q2 24 | $134.1M | $21.2M |
毛利率PLTRVTR
| Q1 26 | — | — | ||
| Q4 25 | 84.6% | — | ||
| Q3 25 | 82.4% | — | ||
| Q2 25 | 80.8% | — | ||
| Q1 25 | 80.4% | — | ||
| Q4 24 | 78.9% | — | ||
| Q3 24 | 79.8% | — | ||
| Q2 24 | 81.0% | — |
营业利润率PLTRVTR
| Q1 26 | — | — | ||
| Q4 25 | 40.9% | 4.9% | ||
| Q3 25 | 33.3% | 3.0% | ||
| Q2 25 | 26.8% | 3.0% | ||
| Q1 25 | 19.9% | 3.0% | ||
| Q4 24 | 1.3% | -0.0% | ||
| Q3 24 | 15.6% | 1.5% | ||
| Q2 24 | 15.5% | -1.6% |
净利率PLTRVTR
| Q1 26 | — | 3.6% | ||
| Q4 25 | 43.3% | 4.7% | ||
| Q3 25 | 40.3% | 4.6% | ||
| Q2 25 | 32.6% | 5.0% | ||
| Q1 25 | 24.2% | 3.6% | ||
| Q4 24 | 9.5% | 4.6% | ||
| Q3 24 | 19.8% | 1.7% | ||
| Q2 24 | 19.8% | 1.8% |
每股收益（稀释后）PLTRVTR
| Q1 26 | — | — | ||
| Q4 25 | $0.24 | $0.15 | ||
| Q3 25 | $0.18 | $0.14 | ||
| Q2 25 | $0.13 | $0.15 | ||
| Q1 25 | $0.08 | $0.10 | ||
| Q4 24 | $0.03 | $0.13 | ||
| Q3 24 | $0.06 | $0.05 | ||
| Q2 24 | $0.06 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.2B | $183.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.4B | $13.2B |
| 总资产 | $8.9B | $27.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PLTRVTR
| Q1 26 | — | $183.6M | ||
| Q4 25 | $7.2B | $741.1M | ||
| Q3 25 | $6.4B | $188.6M | ||
| Q2 25 | $6.0B | $614.2M | ||
| Q1 25 | $5.4B | $182.3M | ||
| Q4 24 | $5.2B | $897.9M | ||
| Q3 24 | $4.6B | $1.1B | ||
| Q2 24 | $4.0B | $557.1M |
总债务PLTRVTR
| Q1 26 | — | — | ||
| Q4 25 | — | $13.0B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $13.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益PLTRVTR
| Q1 26 | — | $13.2B | ||
| Q4 25 | $7.4B | $12.5B | ||
| Q3 25 | $6.6B | $12.4B | ||
| Q2 25 | $5.9B | $11.5B | ||
| Q1 25 | $5.4B | $11.5B | ||
| Q4 24 | $5.0B | $10.8B | ||
| Q3 24 | $4.5B | $9.8B | ||
| Q2 24 | $4.1B | $9.6B |
总资产PLTRVTR
| Q1 26 | — | $27.7B | ||
| Q4 25 | $8.9B | $27.6B | ||
| Q3 25 | $8.1B | $26.9B | ||
| Q2 25 | $7.4B | $26.5B | ||
| Q1 25 | $6.7B | $26.0B | ||
| Q4 24 | $6.3B | $26.2B | ||
| Q3 24 | $5.8B | $25.3B | ||
| Q2 24 | $5.2B | $24.5B |
负债/权益比PLTRVTR
| Q1 26 | — | — | ||
| Q4 25 | — | 1.04× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.26× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $777.3M | — |
| 自由现金流经营现金流 - 资本支出 | $764.0M | — |
| 自由现金流率自由现金流/营收 | 54.3% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | 1.28× | — |
| 过去12个月自由现金流最近4个季度 | $2.1B | — |
8季度趋势，按日历期对齐
经营现金流PLTRVTR
| Q1 26 | — | — | ||
| Q4 25 | $777.3M | $471.7M | ||
| Q3 25 | $507.7M | $378.6M | ||
| Q2 25 | $539.3M | $475.3M | ||
| Q1 25 | $310.3M | $321.1M | ||
| Q4 24 | $460.3M | $373.6M | ||
| Q3 24 | $419.8M | $353.7M | ||
| Q2 24 | $144.2M | $335.9M |
自由现金流PLTRVTR
| Q1 26 | — | — | ||
| Q4 25 | $764.0M | — | ||
| Q3 25 | $500.9M | — | ||
| Q2 25 | $531.6M | — | ||
| Q1 25 | $304.1M | — | ||
| Q4 24 | $457.2M | — | ||
| Q3 24 | $415.8M | — | ||
| Q2 24 | $141.3M | — |
自由现金流率PLTRVTR
| Q1 26 | — | — | ||
| Q4 25 | 54.3% | — | ||
| Q3 25 | 42.4% | — | ||
| Q2 25 | 53.0% | — | ||
| Q1 25 | 34.4% | — | ||
| Q4 24 | 55.3% | — | ||
| Q3 24 | 57.3% | — | ||
| Q2 24 | 20.8% | — |
资本支出强度PLTRVTR
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.4% | — |
现金转化率PLTRVTR
| Q1 26 | — | — | ||
| Q4 25 | 1.28× | 6.46× | ||
| Q3 25 | 1.07× | 5.51× | ||
| Q2 25 | 1.65× | 6.65× | ||
| Q1 25 | 1.45× | 6.64× | ||
| Q4 24 | 5.83× | 6.36× | ||
| Q3 24 | 2.92× | 16.84× | ||
| Q2 24 | 1.08× | 15.87× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLTR
| Geographic Concentration Risk | $1.1B | 77% |
| Other | $330.4M | 23% |
VTR
| Resident fees and services | $1.3B | 78% |
| Outpatient medical and research portfolio | $230.1M | 14% |
| Triple-net leased properties | $123.1M | 7% |
| Third-party capital management revenues | $4.4M | 0% |
